Price
$784.23+6.63%1Y
1M+0.17%1Y+6.63%
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Below average3/10
Value52
Quality39
Momentum28
Growth41
P/E (TTM)-
Market Cap$87.88B
1Y Return+6.63%
5Y Return+311.44%
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q4 2025Total $105.82B (+2.89%)
●Oncology And Multispecialty Segment grew +37.05% YoY●Medical Surgical Solutions Segment +1.42% YoY
SegmentLatestQoQYoY
- North American Pharmaceutical Segment$88.32B+2.13%+8.77%
- Oncology And Multispecialty Segment$13.01B+8.02%+37.05%
- Medical Surgical Solutions Segment$2.99B+1.49%+1.42%
- Prescription Technology Solutions Segment$1.50B+9.01%+9.41%
- Corporate---
- International Segment---
- Prescription Technology Solutions---
- USPharmaceutical Segment---